• Charity News

Girls Aloud members to join forces to raise money in Sarah Harding's honour

The member of Girls Aloud are joining forces with us for a special 'Race for Life for Sarah', raising money for vital breast cancer research in honour of their much-loved bandmate.   The member of Girls Aloud are joining forces with us for a special 'Race for Life for Sarah', raising money for vital breast cancer research in honour of their much-loved bandmate.  

14 June 2022

• Health & Medicine

New study supports extending cervical screening intervals for people who test negative for HPV

A new study confirms that offering cervical screening using HPV testing effectively prevents cervical cancer without the need for as regular screening A new study confirms that offering cervical screening using HPV testing effectively prevents cervical cancer without the need for as regular screening

1 June 2022

• Health & Medicine

NHS ‘understaffed and underequipped’ to tackle cancer, say 3 in 4 people

A new poll, carried out by YouGov, has revealed that three quarters of the UK public think the NHS is understaffed and underequipped to tackle cancer A new poll, carried out by YouGov, has revealed that three quarters of the UK public think the NHS is understaffed and underequipped to tackle cancer

26 May 2022

• Science & Technology

The path to least resistance: How our researchers are outsmarting cancer’s survival skills

Our scientists across the country are working hard to tackle drug resistance – one of cancer's cruellest curveballs. Our scientists across the country are working hard to tackle drug resistance – one of cancer's cruellest curveballs.

25 May 2022

• Personal Stories

Dame Deborah James: why do deeply personal stories resonate with us so much?

Since she was diagnosed in 2016, Dame Deborah James has brought bowel cancer into the spotlight, encouraged people to be aware of the symptoms and seek help if they notice them.  Since she was diagnosed in 2016, Dame Deborah James has brought bowel cancer into the spotlight, encouraged people to be aware of the symptoms and seek help if they notice them. 

24 May 2022

• Health & Medicine

NICE doesn’t recommend ibrutinib drug for those with Waldenstrom’s macroglobulinaemia

Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England

23 May 2022

• Health & Medicine

Immune cell count could determine whether chemotherapy is required in oropharyngeal cancer, new study finds 

A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer. A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

2 May 2022

• Health & Medicine

New insights on self-sampling for cervical cancer screening

Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician. Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician.

27 April 2022

• Health & Medicine

New study identifies how obesity may increase the risk of developing womb cancer

Lifelong excess weight almost doubles a woman’s risk of developing womb cancer, according to a Cancer Research UK-funded study published in BMC Medicine. Lifelong excess weight almost doubles a woman’s risk of developing womb cancer, according to a Cancer Research UK-funded study published in BMC Medicine.

19 April 2022

• Science & Technology

A urine test for bladder cancer: What’s the latest?

Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in. Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in.

16 April 2022

• Health & Medicine

Triple negative breast cancer drug given initial ‘no’ for NHS in England

Sacituzumab govitecan (Trodelvy) is not being recommended by NICE for use in England as a treatment for some people with triple-negative breast cancer. Sacituzumab govitecan (Trodelvy) is not being recommended by NICE for use in England as a treatment for some people with triple-negative breast cancer.

8 April 2022